TGFB1 and hepatocellular carcinoma: Cytokines, such as interleukin 6 (IL-6), interferon alpha (IFNα), transforming growth factor-β (TGF-β), and others, have been investigated as potential biomarkers for predicting ICIs treatment response in various cancers, including HCC (31, 32).